Facilities

WuXi Biologics seals deal for first US production facility

21-May-2020 By Ben Hargreaves

WuXi Biologics signs land deal for a clinical and commercial facility located in Massachusetts.

Moderna's speedy COVID-19 vaccine results not possible alongside CMO, says CEO

19-May-2020 By Ben Hargreaves

Moderna’s CEO comments on positive early results by highlighting the importance of its own manufacturing capabilities.

Thermo Fisher set to build $180m viral vector site

18-May-2020 By Ben Hargreaves

The site will be responsible for commercial manufacturing and will double the company’s viral vector capacity.

US outlines plan for readying coronavirus vaccine by start of 2021

18-May-2020 By Ben Hargreaves

The US government provided details on ‘Operation Warp Speed’ and who will take leadership of the project.

US strikes $138m deal to ensure enough syringes for COVID-19 vaccine

13-May-2020 By Ben Hargreaves

US HHS provides funding in order to boost the number of prefilled syringes available for potential vaccine against coronavirus.

BMS spends $200m to buy bluebird out of CAR-T payments

12-May-2020 By Ben Hargreaves

With the partners’ CAR-T therapy under review by the FDA, BMS chooses to purchase bluebird’s royalty rights and take control of ex-US manufacturing.

Pfizer and BioNTech work to scale up COVID-19 vaccine production

11-May-2020 By Ben Hargreaves

Pfizer identifies four facilities globally to produce vaccine, while BioNTech will increase production at its German facilities.

Regeneron devotes New York facility to COVID-19 cocktail treatment

11-May-2020 By Ben Hargreaves

Regeneron expects an antibody cocktail against coronavirus to be ready for trials in June, plans to utilize entire facility for production.

Catalent takes on manufacture of J&J’s coronavirus vaccine

30-Apr-2020 By Ben Hargreaves

Catalent announces partnership with J&J to manufacture lead COVID-19 vaccine candidate, plans to hire 300 staff and manufacture 24/7.

J&J strikes CDMO deal to add capacity for COVID-19 vaccine

27-Apr-2020 By Ben Hargreaves

J&J agrees a manufacturing partnership with Emergent, as it looks to hit its target of one billion doses.

MilliporeSigma set to build $100m facility for viral and gene therapies

23-Apr-2020 By Ben Hargreaves

The facility will be the company’s second facility in Carlsbad specifically for its BioReliance viral and gene therapy service.

BARDA awards $483m to scale production of Moderna’s COVID vaccine

17-Apr-2020 By Ben Hargreaves

With recruitment for Phase I trials complete, Moderna receives funds to expand manufacturing capacity ready for late-stage trials.

How is the supply chain for immunotherapies impacted by COVID-19?

15-Apr-2020 By Ben Hargreaves

COO of Dendreon explains how ‘every part’ of the supply chain for the company’s lead product has been affected by the novel coronavirus.

Symbiosis doubles footprint of UK biologics site

09-Apr-2020 By Ben Hargreaves

The CMO expands its Sterling site to add new office space, as well as expanding manufacturing space and supporting services.

US FDA closes inspection of Biocon’s insulin facility

02-Apr-2020 By Ben Hargreaves

The company announces that the problems raised by the FDA in February have been cleared.

Product Innovations

Survey Report: State of the global biomanufacturing and bioprocessing industry 2017

In September 2017, BioPharma-Reporter.com conducted its second annual ‘state of the industry’ survey on its user base of biopharmaceutical industry professionals....

Survey Report: State of the Biopharmaceutical Industry 2016

In May 2016, BioPharma-Reporter conducted its inaugural ‘state of the industry’ survey. The key objective of the poll was to gauge views about the current...